THOMPSON DAVIS & CO., INC. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q2 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2018$152,000
+334.3%
880
+252.0%
0.33%
+300.0%
Q2 2018$35,000
+1066.7%
250
+400.0%
0.08%
+2666.7%
Q4 2014$3,0000.0%500.0%0.00%
-40.0%
Q1 2014$3,000500.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2014
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders